BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11986209)

  • 1. In vivo depletion of hematopoietic stem cells in the rat by an anti-CD45 (RT7) antibody.
    Dahlke MH; Lauth OS; Jäger MD; Roeseler T; Timrott K; Jackobs S; Neipp M; Wonigeit K; Schlitt HJ
    Blood; 2002 May; 99(10):3566-72. PubMed ID: 11986209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat.
    Ko S; Jager MD; Tsui TY; Deiwick A; Dinkel A; Rohde F; Dahlke MH; Lauth O; Wonigeit K; Schlitt HJ
    Transplantation; 2001 Apr; 71(8):1124-31. PubMed ID: 11374414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Depleting Anti-CD45 Monoclonal Antibody as Isolated Conditioning for Bone Marrow Transplantation in the Rat.
    Jäger MD; Vondran FW; Ramackers W; Röseler T; Schlitt HJ; Bektas H; Klempnauer J; Timrott K
    PLoS One; 2016; 11(5):e0154682. PubMed ID: 27139494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow aplasia induced by passenger leukocytes from heart allografts.
    Ko S; Dahlke MH; Lauth O; Jäger MD; Deiwick A; Dinkel A; Tsui T; Wonigeit K; Schlitt HJ
    Exp Hematol; 2001 Mar; 29(3):339-44. PubMed ID: 11274762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term donor chimerism after MHC (RT1) mismatched bone marrow transplantation in the rat: the role of host alloreactive NK cells.
    Engh E; Strøm-Gundersen I; Benestad HB; Rolstad B
    Scand J Immunol; 2001; 54(1-2):198-203. PubMed ID: 11439167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
    Alwayn IP; Xu Y; Basker M; Wu C; Buhler L; Lambrigts D; Treter S; Harper D; Kitamura H; Vitetta ES; Abraham S; Awwad M; White-Scharf ME; Sachs DH; Thall A; Cooper DK
    Xenotransplantation; 2001 Aug; 8(3):157-71. PubMed ID: 11472623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulation of CD45 antigen in transplantation tolerance.
    Ko S; Jaeger MD; Dahlke MH; Nakajima Y; Schlitt HJ
    Curr Mol Med; 2002 May; 2(3):249-55. PubMed ID: 12041728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD45-mediated cytoreduction to facilitate allogeneic stem cell transplantation.
    Wulf GG; Luo KL; Goodell MA; Brenner MK
    Blood; 2003 Mar; 101(6):2434-9. PubMed ID: 12433683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR; Taylor PA; Vallera DA
    J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-fixing CD45 monoclonal antibodies to facilitate stem cell transplantation in mouse and man.
    Brenner MK; Wulf GG; Rill DR; Luo KL; Goodell MA; Mei Z; Kuehnle I; Brown MP; Pule M; Heslop HE; Krance RA
    Ann N Y Acad Sci; 2003 May; 996():80-8. PubMed ID: 12799286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX; Fan LY; Wang Q
    Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential representation of B cell subsets in mixed bone marrow chimera mice due to expression of allelic variants of CD45 (CD45.1/CD45.2).
    Basu S; Ray A; Dittel BN
    J Immunol Methods; 2013 Oct; 396(1-2):163-7. PubMed ID: 23928494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis.
    Fritsch G; Buchinger P; Printz D; Fink FM; Mann G; Peters C; Wagner T; Adler A; Gadner H
    Blood; 1993 May; 81(9):2301-9. PubMed ID: 7683216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models.
    Matthews DC; Martin PJ; Nourigat C; Appelbaum FR; Fisher DR; Bernstein ID
    Blood; 1999 Jan; 93(2):737-45. PubMed ID: 9885237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to RT7 and LCA antigens in the rat: cell distribution and segregation analysis.
    Mojcik CF; Greiner DL; Goldschneider I; Lubaroff DM
    Hybridoma; 1987 Oct; 6(5):531-43. PubMed ID: 2960606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
    Vallera DA; Taylor PA; Sprent J; Blazar BR
    Transplantation; 1994 Jan; 57(2):249-56. PubMed ID: 7906058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell depletion of allogeneic bone marrow using anti-alphabetaTCR monoclonal antibody: prevention of graft-versus-host disease without affecting engraftment potential in rats.
    Neipp M; Exner BG; Maru D; Haber M; Gammie JS; Pham SM; Ildstad ST
    Exp Hematol; 1999 May; 27(5):860-7. PubMed ID: 10340402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow.
    Tomita Y; Sachs DH; Sykes M
    Blood; 1994 Feb; 83(4):939-48. PubMed ID: 7906567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation.
    Chen Y; Kornblit B; Hamlin DK; Sale GE; Santos EB; Wilbur DS; Storer BE; Storb R; Sandmaier BM
    Blood; 2012 Feb; 119(5):1130-8. PubMed ID: 22134165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.